Home > Healthcare > Medical Devices > Medical Supplies > Lancet Market

Lancet Market Share

Report ID: GMI6239
Published Date: Jul 2023
Report Format: PDF

Download Free Sample

Lancet Market Share

Some of the eminent market participants operating in the lancet market include

AgaMatrix
Abbott Laboratories
All Medicus Co., Ltd.
Ascensia Diabetes Care Holdings AG
Arkray, Inc
B. Braun Melsungen AG
Bionime Corporation
DarioHealth Corp
Dexcom, Inc.
Essenlife Bioscience, Inc.
F. Hoffmann-La Roche Ltd.
LifeScan Inc.
Medtronic
Nova Biomedical, Inc.
Sinocare Inc.

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

Global market for lancet was worth USD 1.1 billion in 2022 and is estimated to account for USD 1.8 billion by 2032 driven by the growing prevalence of chronic diseases, rising remote patient monitoring trends, favorable reimbursement policies, and the growing adoption of point-of-care testing.

The 23G-33G segment held over 42% share of the lancet industry in 2022 and is anticipated to witness significant growth through 2032 owing to their versatility, optimal balance of comfort and blood volume, clinical recommendations, user preference, and market availability.

The U.S. market generated USD 428.3 million in revenue in 2022 and is poised to witness substantial market growth over 2032 attributed to the presence of the advanced healthcare industry, providing a conducive environment for the utilization of lancets.

AgaMatrix, Abbott Laboratories, All Medicus Co., Ltd., Ascensia Diabetes Care Holdings AG, Arkray, Inc, B. Braun Melsungen AG, Bionime Corporation, DarioHealth Corp., Dexcom, Inc., Essenlife Bioscience, Inc., F. Hoffmann-La Roche Ltd., LifeScan Inc., Medtronic, Nova Biomedical, Inc., and Sinocare Inc. are among the top companies operating in the industry.